paclitaxel has been researched along with Fibrocystic Breast Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rozhin, J; Sameni, M; Sloane, BF; Ziegler, G | 1 |
| Nishimura, Y; Sameni, M; Sloane, BF | 1 |
2 other study(ies) available for paclitaxel and Fibrocystic Breast Disease
| Article | Year |
|---|---|
Pericellular pH affects distribution and secretion of cathepsin B in malignant cells.
Topics: Animals; Cathepsin B; Cell Membrane; Colorectal Neoplasms; Fibrocystic Breast Disease; Humans; Hydrogen-Ion Concentration; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Microtubules; Nocodazole; Paclitaxel; Tumor Cells, Cultured | 1994 |
Malignant transformation alters intracellular trafficking of lysosomal cathepsin D in human breast epithelial cells.
Topics: Animals; Antigens, CD; Biological Transport; Breast; Cathepsin D; Cell Line, Transformed; Cell Transformation, Neoplastic; Cytochalasin D; Epithelial Cells; Female; Fibrocystic Breast Disease; Humans; Immunoglobulin G; Lysosomal Membrane Proteins; Lysosomes; Male; Membrane Glycoproteins; Microscopy, Confocal; Microscopy, Fluorescence; Microtubules; Nocodazole; Oncogene Protein p21(ras); Paclitaxel; Proto-Oncogene Proteins p21(ras); Rabbits; Rats; Recombinant Fusion Proteins; Transfection | 1998 |